電気生理学デバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界の電気生理学デバイスの市場規模は、2023年に69億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.74％のCAGRで拡大し、2030年には120億8,000万米ドルに達すると予測されています。電気生理学デバイスの需要は、主に心血管疾患の有病率の上昇、製品開発における技術進歩、高齢者人口の増加、座りがちなライフスタイル、心血管疾患に関する啓発プログラムの増加によって後押しされています。

世界保健機関（WHO）のデータ（2023年）によると、心血管疾患（CVD）は世界全体の主要な死因であり、この疾患群は毎年推定1,790万人の命を奪っています。さらに、WHOの同じデータでは、CVDによる死亡の5人に4人以上が脳卒中と心臓発作を主な原因としており、これらの死亡の3分の1は70歳未満で早死にすると言われています。CVDによる死亡の4分の3以上は中低所得国で起こっています。

欧州心臓病学会（ESC）のデータ（2023年）によると、毎年、欧州では心血管疾患（CVD）が390万人の死亡原因となっており、欧州連合（EU）では180万人以上が死亡しています。欧州における全死亡の約45％、EUでは37％を占めています。

上記の事実は、世界中で増加するCVDの疾病負担に対処するための対策が切実に必要であることを強調しています。動脈硬化、不整脈、心不全などの適応症は患者のQOLに深刻な影響を及ぼし、生命を脅かすことさえあります。さらに、多くの場合、心臓のリズムや活動を定期的にモニターすることによって、CVDの重症度を軽減することができます。これは、ECGモニターや埋込型心臓モニターなどの電気生理学デバイスを導入することで達成できます。これらの機器により、ヘルスケア提供者だけでなく患者も、必要に応じて心臓の健康状態をモニターすることができます。さらに、ラジオ波や冷凍アブレーションなどのさまざまなアブレーション法を用いた心臓アブレーションなどの高度な電気生理学的処置も、さまざまな病因の心臓疾患を治療する方法を提供します。そのため、電気生理学デバイス市場は、CVDの世界の有病率の上昇を背景に、予測期間中に著しい成長が見込まれます。

しかし、熟練した専門家の数が限られていることや、規制当局の製品承認プロセスが厳しいことが、電気生理学デバイス市場の成長に対する一定の抑制要因になる可能性があります。

当レポートでは、世界の電気生理学デバイス市場について調査し、市場の概要とともに、デバイス別、モダリティ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 電気生理学デバイス市場レポートのイントロダクション

第2章 電気生理学デバイス市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 電気生理学デバイス市場の主な要因分析

• 電気生理学デバイス市場の促進要因
• 電気生理学デバイス市場の抑制要因と課題
• 電気生理学デバイス市場の機会

第5章 電気生理学デバイス市場におけるポーターのファイブフォース分析

第6章 電気生理学デバイス市場の概要

• デバイス別
• モダリティ別
• 用途別
• エンドユーザー別
• 地域別

第7章 電気生理学デバイスの企業と製品プロファイル

• Boston Scientific Corporation
• Lepu Medical Technology（Beijing）Co. Ltd
• GENERAL ELECTRIC COMPANY
• Medtronic
• Abbott
• BIOTRONIK
• Microport Scientific Corporation
• Acutus Medical inc
• Imricor
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• Baylis Medical Company Inc
• Schwarzer Cardiotek GmbH
• ATRICURE, INC
• CardioFocus
• Osypka AG

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Electrophysiology Devices Market in Global (2021-2030)
• Table 3: Electrophysiology Devices Market in Global by Device Type (2021-2030)
• Table 4: Electrophysiology Devices Market in Global by Modality (2021-2030)
• Table 5: Electrophysiology Devices Market in Global by Application (2021-2030)
• Table 6: Electrophysiology Devices Market in Global by End-User (2021-2030)
• Table 7: Electrophysiology Devices Market in Global by Geography (2021-2030)
• Table 8: Electrophysiology Devices Market in North America (2021-2030)
• Table 9: Electrophysiology Devices Market in the US (2021-2030)
• Table 10: Electrophysiology Devices Market in Canada (2021-2030)
• Table 11: Electrophysiology Devices Market in Mexico (2021-2030)
• Table 12: Electrophysiology Devices Market in Europe (2021-2030)
• Table 13: Electrophysiology Devices Market in France (2021-2030)
• Table 14: Electrophysiology Devices Market in Germany (2021-2030)
• Table 15: Electrophysiology Devices Market in the United Kingdom (2021-2030)
• Table 16: Electrophysiology Devices Market in Italy (2021-2030)
• Table 17: Electrophysiology Devices Market in Spain (2021-2030)
• Table 18: Electrophysiology Devices Market in Rest of Europe (2021-2030)
• Table 19: Electrophysiology Devices Market in APAC (2021-2030)
• Table 20: Electrophysiology Devices Market in China (2021-2030)
• Table 21: Electrophysiology Devices Market in Japan (2021-2030)
• Table 22: Electrophysiology Devices Market in India (2021-2030)
• Table 23: Electrophysiology Devices Market in Australia (2021-2030)
• Table 24: Electrophysiology Devices Market in South Korea (2021-2030)
• Table 25: Electrophysiology Devices Market in Rest of APAC (2021-2030)
• Table 26: Electrophysiology Devices Market in the Rest of the World (2021-2030)
• Table 27: Electrophysiology Devices Market in the Middle East (2021-2030)
• Table 28: Electrophysiology Devices Market in Africa (2021-2030)
• Table 29: Electrophysiology Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Electrophysiology Devices Market in Global (2021-2030)
• Figure 3: Electrophysiology Devices Market in Global by Device Type (2021-2030)
• Figure 4: Electrophysiology Devices Market in Global by Modality (2021-2030)
• Figure 5: Electrophysiology Devices Market in Global by Application (2021-2030)
• Figure 6: Electrophysiology Devices Market in Global by End-User (2021-2030)
• Figure 7: Electrophysiology Devices Market in Global by Geography (2021-2030)
• Figure 8: Electrophysiology Devices Market in North America (2021-2030)
• Figure 9: Electrophysiology Devices Market in the US (2021-2030)
• Figure 10: Electrophysiology Devices Market in Canada (2021-2030)
• Figure 11: Electrophysiology Devices Market in Mexico (2021-2030)
• Figure 12: Electrophysiology Devices Market in Europe (2021-2030)
• Figure 13: Electrophysiology Devices Market in France (2021-2030)
• Figure 14: Electrophysiology Devices Market in Germany (2021-2030)
• Figure 15: Electrophysiology Devices Market in the United Kingdom (2021-2030)
• Figure 16: Electrophysiology Devices Market in Italy (2021-2030)
• Figure 17: Electrophysiology Devices Market in Spain (2021-2030)
• Figure 18: Electrophysiology Devices Market in Rest of Europe (2021-2030)
• Figure 19: Electrophysiology Devices Market in APAC (2021-2030)
• Figure 20: Electrophysiology Devices Market in China (2021-2030)
• Figure 21: Electrophysiology Devices Market in Japan (2021-2030)
• Figure 22: Electrophysiology Devices Market in India (2021-2030)
• Figure 23: Electrophysiology Devices Market in Australia (2021-2030)
• Figure 24: Electrophysiology Devices Market in South Korea (2021-2030)
• Figure 25: Electrophysiology Devices Market in Rest of APAC (2021-2030)
• Figure 26: Electrophysiology Devices Market in the Rest of the World (2021-2030)
• Figure 27: Electrophysiology Devices Market in the Middle East (2021-2030)
• Figure 28: Electrophysiology Devices Market in Africa (2021-2030)
• Figure 29: Electrophysiology Devices Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Marker Opportunities
• Figure 33: PORTER'S Five Force Analysis

Electrophysiology Devices Market By Device Type (Treatment Devices [Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Ablation Systems [Radiofrequency, Cryoablation, and Others], and Others], Diagnostic Devices [ECG Monitors [Stress, Rest, and Holter Monitors], Ep X-Ray Systems, Ep Recording Systems, Ep Imaging & Mapping Systems, Implantable Cardiac Monitors, and Others]), Modality (Implantable and External), Application (Ventricular Tachycardia, Atrial Fibrillation, Bradycardia, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to Rising Prevalence of Cardiovascular Diseases and Increasing Advancements in Product Development

The global Electrophysiology Devices Market was valued at USD 6.92 billion in 2023, growing at a CAGR of 9.74% during the forecast period from 2024 to 2030, to reach USD 12.08 billion by 2030. The demand for electrophysiology devices is primarily being boosted by the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness programs regarding cardiovascular diseases.

Electrophysiology Devices Market Dynamics:

As per data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, where this group of diseases accounts for an estimated 17.9 million lives each year. Furthermore, the same data by the WHO presented that over four out of five, CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age. Over three-quarters of CVD deaths take place in low- and middle-income countries.

According to the data provided by the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU.

The above-mentioned facts highlight the dire need for measures to address the rising disease burden of CVDs across the globe. Indications such as atherosclerosis, arrhythmias, and heart failure can severely affect the quality of life of patients and may even prove to be life-threatening. Furthermore, in many cases, the severity of CVDs can be reduced by regular monitoring of cardiac rhythms and activities. This can be achieved by deploying electrophysiology devices such as ECG monitors, and implantable cardiac monitors, among others. These devices enable healthcare providers as well as patients to monitor cardiac health as per the need, i.e. either continuous or periodic monitoring, thereby helping in the improvement of disease prognosis as well helping in early disease diagnosis. Moreover, advanced electrophysiology procedures such as cardiac ablation using different ablation procedures such as radiofrequency and cryoablation also offer a way for treating heart diseases of various etiologies. Therefore, the electrophysiology devices market is expected to witness remarkable growth during the forecast period due to the rising global prevalence of CVDs.

However, the limited availability of skilled professionals and stringent regulatory product approval process may prove to be certain restraints to the electrophysiology devices market growth.

Electrophysiology Devices Market Segment Analysis:

Electrophysiology Devices Market By Device Type (Treatment Devices [Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Ablation Systems [Radiofrequency, Cryoablation, And Others], And Others], Diagnostic Devices [ECG Monitors [Stress, Rest, And Holter Monitors], EP X-Ray Systems, EP Recording Systems, EP Imaging & Mapping Systems, Implantable Cardiac Monitors, And Others]), Modality (Implantable And External), Application (Ventricular Tachycardia, Atrial Fibrillation, Bradycardia, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment, under the diagnostic devices category of the electrophysiology devices market, the ECG monitors segment is expected to amass the largest market share during the forecast period.

ECG systems have been the most commonly used devices for cardiac monitoring. These devices are generally found in hospital setups and have been the conventional and most preferred mode of ECG monitoring of patients. Besides being one of the oldest technologies present, these devices are economical to procure for healthcare facilities, which in turn, makes them an affordable diagnostic procedure for patients.

ECG tests are the preliminary test where cardiac malfunctioning is suspected and where their results become important before proceeding with advanced tests or deciding a treatment approach.

Furthermore, technological advancements and product innovations taking place in the development of ECG devices are likely to propel the electrophysiology devices market growth. For example, in February 2021, Qardio Inc received 510k approval from the US Food and Drug Administration for the QardioCore device, which is an ambulatory ECG monitoring device that can record ECG information for up to 24 hours in a single session.

Hence, owing to the above-mentioned factors the ECG Monitors category is expected to witness growth, thereby propelling the growth of the overall electrophysiology devices market.

North America Is Expected To Dominate The Overall Electrophysiology Devices Market:

Among all the regions, North America is expected to account for the largest share of the electrophysiology devices market. The growing prevalence of cardiovascular diseases such as heart failure and atrial fibrillation, access to better healthcare infrastructure along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the electrophysiology devices market over the forecast period.

As per the facts provided by the Centers for Disease Prevention and Control (CDC), heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States where about 655,000 Americans die from heart disease each year.

As per the data provided by the National Center for Health Statistics, a part of the CDC, in 2018, atrial fibrillation was mentioned as the cause of death in 25,845 deaths and was in the United States. It further stated that approximately 12.1 million people in the United States will have AFib in 2030.

Additionally, a Report by the American Heart Association providing data for 2020 mentioned that nearly about 6.2 million adults in the United States have heart failure. The statistics for 2019 by the same organization stated that in 2018, heart failure was mentioned on 379,800 death certificates in the country. As electrophysiology devices have a major application in detecting heart failure Afib, the increasing number of AFib and heart failure patients in the country is expected to drive the market over the forecast period.

The well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the electrophysiology procedures as well as the treatment devices further encourages people to opt for such procedures and devices.

In June 2021, Medtronic received expanded approval from the US Food and Drug Administration (FDA) for its Arctic Front Family of Cardiac Cryoablation Catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AF).

In June 2020, Boston Scientific Corporation received 510k approval from the US Food and Drug Administration for the LUX-Dx(TM) Insertable Cardiac Monitor (ICM) System which is a long-term implantable diagnostic device for the detection of arrhythmias associated with conditions such as cryptogenic stroke, atrial fibrillation (AF), and syncope.

Considering the presence of a large patient pool in the US coupled with new product launches, the market for electrophysiology devices looks promising in the United States.

Electrophysiology Devices Market Key Players:

Some of the key market players operating in the electrophysiology devices market include Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd, GENERAL ELECTRIC COMPANY, Medtronic, Abbott, BIOTRONIK, Microport Scientific Corporation, Acutus Medical, Inc., Imricor, Medical Devices Business Services, Inc. (Johnson & Johnson), Baylis Medical Company, Inc, Schwarzer Cardiotek GmbH, ATRICURE, INC., CardioFocus, Osypyka AG and others.

Recent Developmental Activities in Electrophysiology Devices Market:

In December 2020, Acutus Medical Inc announced the launch of their AcQBlate® Force Sensing Ablation System in Europe after securing the CE Mark for the company's AcQBlate FORCE ablation catheter and the Qubic Force Sensing Module (Qubic Force).

In November 2020, Abbott received the CE mark and Approval from the Australian Regulatory Authority for their EnSite(TM) X EP System, which is equipped with advanced imaging capabilities and allows for the creation of a 3D model of the cardiac anatomy of patients. This system is developed to offer electrophysiologists a smoother platform to help deliver ablation therapy to treat abnormal heart rhythms.

In January 2020, Imricor received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This is the first and only company to offer cardiac ablation devices for use in the MRI environment.

Key Takeaways from the Electrophysiology Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the electrophysiology devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Electrophysiology Devices Market.

Various opportunities are available for the other competitor in the Electrophysiology Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current electrophysiology devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for electrophysiology devices market growth in the coming future?

Target Audience who can be benefited from this Electrophysiology Devices Market Report Study

Electrophysiology device products providers

Research organizations and consulting companies

Electrophysiology Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in electrophysiology devices

Various End-users who want to know more about the Electrophysiology Devices market and the latest technological developments in the Electrophysiology Devices market.

Frequently Asked Questions for Electrophysiology Devices Market:

What is an Electrophysiology Device?

An electrophysiology device helps in the assessment of the electrical activity of the heart. These devices help in the diagnosis as well as in the treatment of diseases related to the electrical system of the heart.

What is the market for Global Electrophysiology Devices?

Global Electrophysiology Devices Market was valued at USD 6.92 billion in 2023, growing at a CAGR of 9.74% during the forecast period from 2024 to 2030, to reach USD 12.08 billion by 2030.

What are the drivers for Global Electrophysiology Devices Market?

The major drivers of the global electrophysiology devices market are the rising cardiovascular disease prevalence, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing focus on making people aware of cardiovascular diseases.

What are the key players operating in Global Electrophysiology Devices Market?

Some of the major players operating in the electrophysiology devices market include Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd, GENERAL ELECTRIC COMPANY, Medtronic, Abbott, BIOTRONIK, Microport Scientific Corporation, Acutus Medical, Inc., Imricor, Medical Devices Business Services, Inc. (Johnson & Johnson), Baylis Medical Company, Inc, Schwarzer Cardiotek GmbH, ATRICURE, INC., CardioFocus, Osypyka AG and others.

What region has the highest share in the Electrophysiology Devices market?

North America is expected to account for the largest revenue share in the overall electrophysiology devices market during the forecast period, 2024 to 2030. This high growth in the market can be attributed to the increasing prevalence of cardiovascular diseases such as atrial fibrillation and heart failure and encouraging reimbursement policies in the region, especially in the US.

Table of Contents

1. Electrophysiology Devices Market Report Introduction

2. Electrophysiology Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Electrophysiology Devices Market Key Factors Analysis

• 4.1. Electrophysiology Devices Market Drivers
  • 4.1.1. Increasing Prevalence of Cardiovascular Diseases
  • 4.1.2. Rising Sedentary Lifestyle
  • 4.1.3. Increasing Geriatric Population
  • 4.1.4. Increasing Awareness Programs Regarding Cardiovascular Diseases
• 4.2. Electrophysiology Devices Market Restraints and Challenges
  • 4.2.1. Limited availability of skilled professionals
  • 4.2.2. Stringent Regulatory Product Approval Process
• 4.3. Electrophysiology Devices Market Opportunities
  • 4.3.1. Improving Product Safety
  • 4.3.2. Targeting Emerging Markets for Product Launches

5. Electrophysiology Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Electrophysiology Devices Market Layout

• 6.1. By Devices
  • 6.1.1. Treatment Devices
    • 6.1.1.1. Defibrillators
    • 6.1.1.2. Pacemakers
    • 6.1.1.3. Cardiac Resynchronization Therapy Devices
    • 6.1.1.4. Ablation Systems
    • 6.1.1.4.1. Radiofrequency
    • 6.1.1.4.2. Cryoablation
    • 6.1.1.4.3. Others
    • 6.1.1.5. Others
  • 6.1.2. Diagnostic Devices
    • 6.1.2.1. ECG Monitors
    • 6.1.2.1.1. Stress
    • 6.1.2.1.2. Rest
    • 6.1.2.1.3. Holter Monitors
    • 6.1.2.2. EP X-Ray Systems
    • 6.1.2.3. EP Recording Systems
    • 6.1.2.4. EP Imaging & Mapping Systems
    • 6.1.2.5. Implantable Cardiac Monitors
    • 6.1.2.6. Others
• 6.2. By Modality
  • 6.2.1. Implantable
  • 6.2.2. External
• 6.3. By Application
  • 6.3.1. Ventricular Tachycardia
  • 6.3.2. Atrial Fibrillation
  • 6.3.3. Bradycardia
  • 6.3.4. Others
• 6.4. By End-User
  • 6.4.1. Hospitals
  • 6.4.2. Ambulatory Surgical Centers
  • 6.4.3. Others
• 6.5. By Geography
  • 6.5.1. North America Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.1.1. United States Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.1.2. Canada Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.1.3. Mexico Electrophysiology Devices Market in USD million (2021-2030)
  • 6.5.2. Europe Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2.1. France Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2.2. Germany Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2.3. United Kingdom Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2.4. Italy Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2.5. Spain Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2.6. Rest of Europe Electrophysiology Devices Market in USD million (2021-2030)
  • 6.5.3. Asia-Pacific Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3.1. China Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3.2. Japan Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3.3. India Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3.4. Australia Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3.5. South Korea Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3.6. Rest of Asia-Pacific Electrophysiology Devices Market in USD million (2021-2030)
  • 6.5.4. Rest of the World (RoW) Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.4.1. Middle East Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.4.2. Africa Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.4.3. South America Electrophysiology Devices Market in USD million (2021-2030)

7. Electrophysiology Devices Company and Product Profiles

• 7.1. Boston Scientific Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Lepu Medical Technology (Beijing) Co. Ltd
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. GENERAL ELECTRIC COMPANY
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Medtronic
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Abbott
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. BIOTRONIK
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Microport Scientific Corporation
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Acutus Medical inc
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Imricor
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Medical Devices Business Services, Inc. (Johnson & Johnson)
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Baylis Medical Company Inc
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Schwarzer Cardiotek GmbH
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. ATRICURE, INC
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. CardioFocus
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Osypka AG
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us